Different Mechanisms Mediate Development and Expression of Tolerance and Dependence for Peripheral μ-Opioid Antinociception in Rat
Open Access
- 15 October 1997
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 17 (20) , 8018-8023
- https://doi.org/10.1523/jneurosci.17-20-08018.1997
Abstract
The μ-opioid [d-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAMGO) exerts a peripheral antinociceptive effect against prostaglandin E2(PGE2)-induced mechanical hyperalgesia in the hindpaw of the rat. Tolerance and dependence develop to this effect. We have shown previously that tolerance and dependence can be dissociated and are mediated by different second messenger systems. In the present study, we evaluated whether the same or different second messenger systems mediate thedevelopmentof this peripheral opioid tolerance or dependence compared with theexpressionof the loss of antinociceptive effect or rebound opioid antagonist hyperalgesia (i.e., expression of tolerance and dependence). DAMGO-induced tolerance was prevented by pretreatment with the nitric oxide synthase inhibitorNG-methyl-l-arginine (NMLA) but not by the protein kinase C (PKC) inhibitor chelerythrine, the adenylyl cyclase inhibitor 2′,5′-dideoxyadenosine (ddA), or the calcium chelators 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-octyl ester (TMB-8) and 2-[(2-bis-[carboxymethyl]amino-5-methylphenoxy)-methyl]-6-methoxy-8-bis[carboxymethyl]aminoquinoline (Quin-2). Once established, however, expression of DAMGO tolerance was acutely reversed by TMB-8 or Quin-2 but not by chelerythrine or NMLA. In contrast, naloxone-precipitated hyperalgesia in DAMGO-tolerant paws, a measure of dependence, was blocked by pretreatment with chelerythrine but not by NMLA, ddA, TMB-8, or Quin-2. Naloxone-precipitated hyperalgesia in DAMGO-tolerant paws was acutely reversed by chelerythrine, ddA, TMB-8, or Quin-2 but not by NMLA. Taken together, these results provide the first evidence that different mechanisms mediate the development and expression of both tolerance and dependence to the peripheral antinociceptive effect of DAMGO. However, although the development of tolerance and dependence are entirely separable, the expression of tolerance and dependence shares common calcium-dependent mechanisms.Keywords
This publication has 29 references indexed in Scilit:
- Basal phosphorylation of μ opioid receptor is agonist modulated and Ca2+‐dependentFEBS Letters, 1996
- Effect of spinal infusion of l-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the ratNeuroscience Letters, 1996
- The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate AddictionNeuropsychopharmacology, 1995
- Nitric Oxide Synthase Inhibitors Preclinical Studies of Potential Use for Treatment of Opioid WithdrawalNeuropsychopharmacology, 1995
- Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant miceBrain Research, 1995
- Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthaseGeneral Pharmacology: The Vascular System, 1995
- Peripheral Opioid ReceptorsAnnals of Medicine, 1995
- Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl esterLife Sciences, 1993
- Peripheral analgesic actions of opioidsJournal of Pain and Symptom Management, 1991
- C-Kinase activation prolongs Ca2+-dependent inactivation of K+ currentsBiochemical and Biophysical Research Communications, 1986